欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/1513/001
药品名称Rabeprazol "Medical Valley"
活性成分
    • rabeprazole sodium salt 10.0 mg
剂型Gastro-resistant tablet
上市许可持有人Medical Valley Invest AB Brädgårdsvägen 28 236 32 Höllviken Sweden
参考成员国 - 产品名称Denmark (DK)
Rabeprazolnatrium Liconsa
互认成员国 - 产品名称
    • Iceland (IS)
    • Portugal (PT)
    • Greece (GR)
      RABEPRAZOLE/LICONSA
    • Hungary (HU)
      RABEPRAZOLE LICONSA 10 mg gyomornedv-ellenálló tabletta
许可日期2009/06/30
最近更新日期2024/04/04
药物ATC编码
    • A02BC04 rabeprazole
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase